Haircare, Salon Trends and Hair-Loss Science — 2026-09-04

Top developments

Hair-Loss Drug Stocks Surge as "Next Big Bet" After GLP-1

Investors are increasingly viewing hair-loss treatments as the next major growth sector following the success of obesity drugs. Bloomberg reports that stocks for companies tackling baldness have soared, with capital flowing into firms developing novel therapies for androgenetic alopecia. This shift reflects a market desire for high-margin, purely aesthetic solutions with broad consumer appeal, distinct from the medical necessity framing of weight-loss drugs

Dyson Launches First Dryer Brush and New Straightener at IFA 2026

Dyson unveiled its first-ever dryer brush and a new hair straightener during its product showcase at IFA 2026 in Berlin. The new tools are designed to deliver sleek, soft locks while minimizing frizz and heat damage, expanding the brand's portfolio beyond the Airwrap and Supersonic. This launch reinforces Dyson's dominance in the premium hair-tool market as competitors like Shark continue to offer lower-cost alternatives

New Oral Pill Outperforms Minoxidil in Phase 2/3 Trials

A new investigational oral hair-loss pill, VDPHL01, has cleared Phase 2/3 trials, showing superior efficacy compared to minoxidil and finasteride in early studies. Study investigator Michael Gold, MD, highlighted the drug's potential to offer better results with a more favorable safety profile, marking a significant step forward in clinical hair-loss research. This development adds to the growing pipeline of non-topical treatments aiming to address male and female pattern baldness

Japanese Market Sees Premium Scalp Serum Launches and Best Cosmetics Awards

In Japan, luxury brand Sisley launched the "Hair Ritual Fortifying Serum for the Scalp Advanced" on September 1, priced at ¥47,300 (approx. $335), targeting aging scalp concerns with advanced formulas. Simultaneously, smart magazine announced its first-half 2026 best cosmetics awards, highlighting a ¥8,250 scalp serum as a top performer for combating dryness and aging, reflecting strong consumer demand for affordable yet effective scalp care

Local view

Japan: The Japanese beauty industry is seeing a bifurcation between ultra-premium and mass-market effective scalp care. Fashionsnap reports Sisley's high-end serum launch, while smart magazine's awards highlight accessible products, indicating a robust market across price points.

Korea: Korean media highlights the international expansion of domestic K-beauty haircare brands. Korea Daily reports that a popular brush-integrated hair-loss ampoule, which topped Olive Young rankings, is launching in the US, catering to the Korean diaspora and broader American interest in K-beauty scalp solutions.

Japan: TPC Marketing Research notes that the Japanese haircare market is shifting from stagnation to gradual growth, driven by product innovations focused on specific scalp needs rather than general cleansing.

Context & numbers

The global hair loss medication market is projected to reach US$8.65 billion by 2035, growing at a CAGR of 5.62% from a valuation of USD 5.12 billion in 2025. This financial outlook underscores why Wall Street is aggressively funding hair-loss biotech startups.

On the radar

• VDPHL01 Regulatory Path: Following positive Phase 2/3 results, watch for FDA submission timelines or further Phase 3 data releases for this promising oral treatment.
• Sisley Scalp Serum Reception: Monitor sales performance of the ¥47,300 serum in Asian luxury markets as a benchmark for premium scalp care pricing power.
• Dyson Tool Availability: Look for regional release dates and initial consumer reviews for the newly announced Dyson dryer brush and straightener, which are expected to hit major markets in late 2026.